PATENT CLAIM ANALYSIS

Application Number: 15761081
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "622000"]

Abstract:
The present disclosure describes a method of treating p53-deficient cells using a niclosamide derivative according to formula (I). The present disclosure further describes a method of treating cancer using the compound according to formula I, as well as methods of screening to identify a compound that selectively target cells wherein p53 is deficient or non-functional.

Claim (Index 3):
The method of  claim 1 , wherein R 1  is H or halide; optionally wherein R 1  is Cl.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.53846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14408748', '14901314', '14950033', '12604970', '10716100']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7868832984653055
- 35 USC 102 Novelty (BERT): 0.5236798651056175
- Combined Prediction Score: 0.7605629551293367
- Mean Citation Score: 283.18594799999994
- Max Citation Score: 295.15762
- Similarity Product: 167.3152887049437

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test